These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 15946653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.
    Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE.
    J Exp Med; 2004 Dec 20; 200(12):1667-72. PubMed ID: 15611292
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Erythropoietin treatment improves neurological functional recovery in EAE mice.
    Zhang J, Li Y, Cui Y, Chen J, Lu M, Elias SB, Chopp M.
    Brain Res; 2005 Feb 09; 1034(1-2):34-9. PubMed ID: 15713257
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Oral zinc aspartate treats experimental autoimmune encephalomyelitis.
    Schubert C, Guttek K, Grüngreiff K, Thielitz A, Bühling F, Reinhold A, Brocke S, Reinhold D.
    Biometals; 2014 Dec 09; 27(6):1249-62. PubMed ID: 25146336
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli.
    Nieuwenhuis EE, Visser MR, Kavelaars A, Cobelens PM, Fleer A, Harmsen W, Verhoef J, Akkermans LM, Heijnen CJ.
    Arthritis Rheum; 2000 Nov 09; 43(11):2583-9. PubMed ID: 11083284
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interferon beta modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion.
    Yasuda CL, Al-Sabbagh A, Oliveira EC, Diaz-Bardales BM, Garcia AA, Santos LM.
    Immunol Invest; 1999 Nov 09; 28(2-3):115-26. PubMed ID: 10484677
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis.
    Buenafe AC, Bourdette DN.
    J Neuroimmunol; 2007 Jan 09; 182(1-2):32-40. PubMed ID: 17055066
    [Abstract] [Full Text] [Related]

  • 36. Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
    He J, Wang Y, Kastin AJ, Pan W.
    Brain Behav Immun; 2014 May 09; 38():53-8. PubMed ID: 24566387
    [Abstract] [Full Text] [Related]

  • 37. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons.
    Brod SA, Burns DK.
    Neurology; 1994 Jun 09; 44(6):1144-8. PubMed ID: 8208413
    [Abstract] [Full Text] [Related]

  • 38. Behavioral aspects of experimental autoimmune encephalomyelitis.
    Pollak Y, Ovadia H, Goshen I, Gurevich R, Monsa K, Avitsur R, Yirmiya R.
    J Neuroimmunol; 2000 Apr 03; 104(1):31-6. PubMed ID: 10683512
    [Abstract] [Full Text] [Related]

  • 39. Protective mechanisms by omega-6 lipids in experimental autoimmune encephalomyelitis (EAE) are associated with cytokines and eicosanoids.
    Harbige LS, Layward L, Morris M, Amor S.
    Biochem Soc Trans; 1997 May 03; 25(2):342S. PubMed ID: 9191387
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.